Rasmus Irming Jølck

Corporate Officer/Principal en Nanovi Radiotherapy A/S .

Health Technology

Consumer Services

Perfil

Rasmus Irming Jølck is currently working as a Development Director at Nanovi Radiotherapy A.
Prior to this, he worked as a Principal at Technical University of Denmark.

Cargos activos de Rasmus Irming Jølck

Empresas	Cargo	Inicio
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Corporate Officer/Principal	-

Todos los cargos activos de Rasmus Irming Jølck

Antiguos cargos conocidos de Rasmus Irming Jølck.

Empresas	Cargo	Fin
Technical University of Denmark	Corporate Officer/Principal	03/11/2014

Ver el detalle de la experiencia de Rasmus Irming Jølck.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Rasmus Irming Jølck.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Health Technology